Public misunderstanding of pivotal COVID-19 vaccine trials may contribute to New Zealand's adoption of a costly and economically inefficient vaccine mandate
Year of publication: |
2023
|
---|---|
Authors: | Gibson, John K. |
Published in: |
New Zealand economic papers. - London [u.a.] : Routledge, Taylor & Francis Group, ISSN 1943-4863, ZDB-ID 2400373-6. - Vol. 57.2023, 1, p. 31-40
|
Subject: | cost-benefit analysis | COVID-19 | information | randomized control trials | vaccines | Coronavirus | Impfung | Vaccination | Neuseeland | New Zealand | Kosten-Nutzen-Analyse | Cost-benefit analysis | Arzneimittel | Pharmaceuticals | Wirkungsanalyse | Impact assessment | Gesundheitspolitik | Health policy | Infektionskrankheit | Infectious disease |
-
Export controls on COVID-19 vaccines : has the EU opened pandora’s box?
Evenett, Simon J., (2021)
-
Distributing a billion vaccines : COVAX successes, challenges, and opportunities
Budish, Eric B., (2022)
-
Refueling a quiet fire : old truthers and new discontent in the wake of Covid-19
Beccari, Gabriele, (2023)
- More ...
-
Friedman, Jed, (2016)
-
Stillman, Steven, (2012)
-
Rice self-sufficiency and the terms of trade : why rice is a good thing to import
Gibson, John K., (1993)
- More ...